Lynk Pharmaceuticals Co., Ltd. announced that China’s National Medical Products Administration (NMPA) has granted clearance...
CF PharmTech Inc. (HKG: 2652) announced that China’s National Medical Products Administration (NMPA) has granted...
Peijia Medical Ltd. (HKG: 9996) announced an exclusive distribution agreement with B. Braun Melsungen AG...
Basecare Medical Device Co., Ltd. (HKG: 2170), a specialist in high-throughput sequencing-based assisted reproduction technologies,...
Shandong Boan Biotechnology Co., Ltd. (HKG: 6955) announced the submission of Biologics License Applications (BLAs)...
Hanmi Pharm. Co., Ltd. (“Hanmi”) announced a strategic global licensing agreement with Eli Lilly (NYSE:...
Shanghai Henlius Biotech Inc. (HKG: 2696) announced that the National Medical Products Administration (NMPA) has...
Guangdong True Health Medical Technology Development Co., Ltd., a leading Chinese developer of percutaneous puncture...
Chengdu Kanghua Biological Products Co., Ltd. (SHE: 300841) announced the initiation of a Phase II...
AbbVie (NYSE: ABBV) announced that the European Commission (EC) has granted an expanded marketing authorization...
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. (SHA: 603392) announced the nationwide commercial launch of...
Bristol-Myers Squibb (BMS; NYSE: BMY) announced positive late-breaking results from the Phase 3 SUCCESSOR-2 trial...
AstraZeneca (NASDAQ: AZN) announced that the U.S. Food and Drug Administration (FDA) has approved IMFINZI...
Merck & Co., Inc. (MSD; NYSE: MRK) announced that the U.S. Food and Drug Administration...
Eli Lilly and Company (NYSE: LLY) announced groundbreaking results from the Phase 3 LIBRETTO-432 clinical...
China’s National Medical Products Administration (NMPA) has released the “2026 Adjustment Work Plan for the...
The Center for Drug Evaluation (CDE) of China’s National Medical Products Administration (NMPA) has included...
The U.S. Food and Drug Administration (FDA) released draft guidance aimed at reducing unnecessary animal...